1673-5269
2016 Issue 6
..............page:342
Relevance of non-small cell lung cancer and rare earth elements
LI Shao-jin;ZHANG Xiang-min;LIU Lian-bin;ZHOU Mao-hua;YE Gui-lin;YE Yong-qiang;XIE Chuan-hua;WANG Gang;Department of Laboratory;Ganzhou Institute of Cancer Research;Tumor Hospital of Ganzhou;
LI Shao-jin;ZHANG Xiang-min;LIU Lian-bin;ZHOU Mao-hua;YE Gui-lin;YE Yong-qiang;XIE Chuan-hua;WANG Gang;Department of Laboratory;Ganzhou Institute of Cancer Research;Tumor Hospital of Ganzhou;
..............page:347-351
Effects of erlotinib combined with X-ray radiation on growth of the esophageal carcinoma cells KYSE450
YUAN Qiang;LAN Sheng-min;GUO Ru-yuan;LI Hong-wei;CAO Jian-zhong;Department of Medical Imaging;Shanxi Medical University;Shanxi Medical University Affiliated Tumor Hospital;Shanxi Cancer Hospital;Radiotherapy Center of Shanxi Province;
YUAN Qiang;LAN Sheng-min;GUO Ru-yuan;LI Hong-wei;CAO Jian-zhong;Department of Medical Imaging;Shanxi Medical University;Shanxi Medical University Affiliated Tumor Hospital;Shanxi Cancer Hospital;Radiotherapy Center of Shanxi Province;
..............page:352-357
..............page:357
Expression of SIRT1and its clinical significance in lung adenocarcinoma tissues
MING Hao;XIE Quan-qin;ZONG Yun;LI Chong;JIANG Jing-ting;Third Affiliated Hospital of Soochow University;
MING Hao;XIE Quan-qin;ZONG Yun;LI Chong;JIANG Jing-ting;Third Affiliated Hospital of Soochow University;
..............page:358-363
..............page:363
Correlation with advanced NSCLC T790M EGFR-TKI secondary resistance and prognosis
WEI Yuan;WEI Li;MA Xiao-ping;MA Xin-yu;GONG Ping;Department of Oncology;First Affiliated Hospital;Medical College;Shihezi University;Department of Ultrasound Diagnosis;Shihezi Municipal People’s Hospital;
WEI Yuan;WEI Li;MA Xiao-ping;MA Xin-yu;GONG Ping;Department of Oncology;First Affiliated Hospital;Medical College;Shihezi University;Department of Ultrasound Diagnosis;Shihezi Municipal People’s Hospital;
..............page:364-368
Relationship between EGFR mutations and clinicopathological features in NSCLC and prognostic analysis of TKI treatment
YAO Xiao-yan;SHEN Shu-jing;WANG Ye;LI Xing-ya;Department of Medical Oncology;First Affiliated Hospital of Zhengzhou University;
YAO Xiao-yan;SHEN Shu-jing;WANG Ye;LI Xing-ya;Department of Medical Oncology;First Affiliated Hospital of Zhengzhou University;
..............page:369-372
Contrast-enhanced CT and Ki-67antigen expression in limited-stage small cell lung cancer
ZHANG Rong-rong;LI Wen-wu;ZUO Wen-shu;XU Liang;HUANG Yong;ZHANG Jian-bo;WANG Hai-peng;School of Medicine and Life Sciences;University of Jinan-Shandong Academy of Medical Sciences;Shandong Cancer Hospital Affiliated to Shandong University;
ZHANG Rong-rong;LI Wen-wu;ZUO Wen-shu;XU Liang;HUANG Yong;ZHANG Jian-bo;WANG Hai-peng;School of Medicine and Life Sciences;University of Jinan-Shandong Academy of Medical Sciences;Shandong Cancer Hospital Affiliated to Shandong University;
..............page:373-377
Prognosis of different postoperative treatment modalities in esophageal adenocarcinoma
LI Na;WANG Jun;LI Jing;CAO Feng;WANG Yi;CHENG Yun-jie;LIU Qing;JING Shao-wu;YANG Cong-rong;WU Ya-jing;GUO Yin;Department of Radiation Oncology;Fourth Hospital of Hebei Medical University;
LI Na;WANG Jun;LI Jing;CAO Feng;WANG Yi;CHENG Yun-jie;LIU Qing;JING Shao-wu;YANG Cong-rong;WU Ya-jing;GUO Yin;Department of Radiation Oncology;Fourth Hospital of Hebei Medical University;
..............page:378-383
..............page:383
Dosimetric comparison of two different hybird VMAT techniques for thoracic esophageal carcinoma
YANG Jin-lei;YANG Zhu-chun;YAN Ling;BU Ming-wei;LU Shuang-chen;HUANG Wei;LIU Bo-yu;Department of Radiation Oncology;Jilin Cancer Hospital;Department of Radiation Oncology;Second Hospital;Jilin University;
YANG Jin-lei;YANG Zhu-chun;YAN Ling;BU Ming-wei;LU Shuang-chen;HUANG Wei;LIU Bo-yu;Department of Radiation Oncology;Jilin Cancer Hospital;Department of Radiation Oncology;Second Hospital;Jilin University;
..............page:384-388
..............page:388
Comparison of Icotinib versus Docetaxel as second-line treatment of advanced lung adenocarcinoma
LIU Qing-cun;HE Wei;FAN Qing-xia;Department of Oncology;First Affiliated Hospital of Zhengzhou University;
LIU Qing-cun;HE Wei;FAN Qing-xia;Department of Oncology;First Affiliated Hospital of Zhengzhou University;
..............page:389-393
Evaluation time window and method of the recent curative effect after radiotherapy of cystic lung cancer with brain metastasis
LIU Yu-feng;SU Sheng-fa;OUYANG Wei-wei;MA Zhu;LI Qing-song;WANG Yu;LI Hui-qin;LU Bing;Oncology Teaching and Research Section of Guizhou Medical University;Department of Thoracic Oncology;Affiliated Hospital of Guizhou Meidical University;Guizhou Province Tumor Hospital;
LIU Yu-feng;SU Sheng-fa;OUYANG Wei-wei;MA Zhu;LI Qing-song;WANG Yu;LI Hui-qin;LU Bing;Oncology Teaching and Research Section of Guizhou Medical University;Department of Thoracic Oncology;Affiliated Hospital of Guizhou Meidical University;Guizhou Province Tumor Hospital;
..............page:394-399
Effect of IHPC on perioperative period of renal function in patients with colon cancer
ZHANG Huan-hu;GONG Qing;HAN Chuan-ji;ZHAN Zhi-yong;Department of Gastrointestinal Surgery;Weihai Municipal Hospital;
ZHANG Huan-hu;GONG Qing;HAN Chuan-ji;ZHAN Zhi-yong;Department of Gastrointestinal Surgery;Weihai Municipal Hospital;
..............page:400-402
Prognostic value of FGFR2 overexpression and amplification in gastric cancer:A Meta-analysis
XIE Zhong-yi;WU Ying;ZHENG Shu-fang;Graduate School;Tianjin University of Traditional Chinese Medicine;Department of Pathology;Affiliated Hospital of Logistical College of the Chinese People’s Armed Police Force;
XIE Zhong-yi;WU Ying;ZHENG Shu-fang;Graduate School;Tianjin University of Traditional Chinese Medicine;Department of Pathology;Affiliated Hospital of Logistical College of the Chinese People’s Armed Police Force;
..............page:403-408
..............page:409-410